High-titer retroviral pseudotype vectors for specific targeting of human CD4-positive cells

Biogenic Amines

Volumn 14, Issue 5, 1998, Pages 407-424

  Stitz, J ^a   Muller, P ^a   Merget Millitzer, H ^a   Cichutek, K ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

CD4 expressing human cells; Cell targeting; Gene therapy; HIV 1; MLV vectors; Pseudotyping; Vector concentration procedures

Indexed keywords

CD4 ANTIGEN; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; RETROVIRUS; REVIEW; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0031671544     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Ager, S., Nilson, B.H.K., Morling, F.J., Peng, K.W., Cosset, F.-L. and Russell, S.J. (1996). Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum. Gene Ther., 7: 2157-2164.
2. Anderson, F.W. (1984). Prospects for human gene therapy. Science, 226: 401-409.
3. Blaese, M.R., Culver, K.W., Miller, A.D., Carter, C.S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstohev, P., Greenblatt, J.J., Rosenberg, S.A., Klein, H., Berger, M., Mullen, C.A., Ramsey, W.J., Muul, L., Morgan, R.A. and Anderson, W.F. (1995). T Lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science, 270: 475-480.
4. Bruunsgaard, H., Pedersen, C., Scheibel, E. and Pedersen, B.K. (1995). Increase in percentage of CD45RO+ / CD8+ cells is associated with previous severe primary HIV infection. JAIDS, 10: 107-114.
5. Chesebro, B., Wehrly, K., Metcalf, J. and Griffin, D.E. (1991). Use of a new CD4-positive HeLa cell clone for direct quantivication of infectious human immunodeficiency virus from blood cells of AIDS patients. J. Infect. Dis., 163: 64-70.
6. Chu, T., Martinez, I., Sheay, W.C. and Dornburg, R. (1994). Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther., 1: 292-299.
7. Cosset, F.-L., Tackeuchi, Y., Battini, J.-L., Weiss, R.A. and Collins, M.K.I. (1995). High-titer packaging cells producing recombinant retroviruses resistent to human serum. J. Virol., 69: 7430-7436.
8. D'Souza, M.P. and Harden V.A. (1996). Chemokines and HIV-1 second receptors. Nature Med., 2: 1293-1300.
9. Eiden, M.V., Farrel, K.B. and Wilson, C.A. (1996). Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as gibbon ape leukemia virus receptor. J. Virol., 70: 1080-1085.
10. Hill, C.M., Deng, H., Unutmaz, D., Kewalramani, V.N., Bastiani, L., Gorny, M.K., Zolla-Pazner, S. and Littman, D.R. (1997). Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a co-receptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol., 71: 6296-6304.
11. Kalle, C., Kiem, H.-P., Goehle, S., Darovsky, B., Heimfeld, S., Torok-Strob, B., Strob, R. and Schuening, F.G. (1994). Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood, 84: 2890-2897.
12. Kavanaugh, M.P., Miller, D.G., Zhang, W., Law, W., Kozak, S.L., Kabat, D., Miller, D.A. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA, 91: 7071-7075.
13. Kozak, S.L., Siess, D.C., Kavanaugh, M.P., Miller, A.D. and Kabat, D. (1995). The envelope glycoproteins of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol., 69: 3433-3440.
14. Landau, N.R. and Littamn, D.R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol., 66: 5110-5113.
15. Lewis, N., Williams, J., Rekosh, D. and Hammarskjöld, M.-L. (1990). Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex protein. J. Virol., 64: 1690-1697.
16. Luft, J.H. (1964). Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol., 9: 109-113.
17. Mammano, F., Salvatori, F., Indraccolo, S., De Rossi, A., Chieco-Bianchi, L. and Göttlinger, H.G. (1997). Truncation of the immunodeficiency virus type 1 envelope allows efficient pseudotyping of murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol., 71: 3341-3345.
18. Markowitz, D., Goff, S. and Bank, A. (1988). Construction and use of a safe and efficient amphotropic packaging cell line. Virology, 167: 400-406.
19. Pomerantz, R.J. and Trono, D. (1995). Genetic therapies for HIV infections: promise for the future. AIDS, 9: 985-993.
20. Richardson, C. and Bank, A. (1996). Developmental-stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells. Mol. Cell. Biol., 16: 4240-4247.
21. Sattentau, Q.J., Dalgleish, A.G., Weiss, R.A. and Beverley P.C.L. (1986). Epitopes of the CD4 antigen and HIV infection. Science, 234: 1120-1123.
22. Schnierle, B.S., Stitz, J., Bosch, V., Nocken, F., Merget-Millitzer, H., Engelstädter, M., Kurth, R. and Cichutek, K. (1997). Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells, Proc. Natl. Acad. Sci. USA, 94: 8640-8645.
23. Somia, N.V., Zoppe, M. and Verma, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc. Natl. Acad. Sci. USA, 92: 7570-7574.
24. Vile, R.G., Schulz, T.F., Danos, O.F., Collins, M.K.L. and Weiss, R.A. (1991). A murine cell line producing HTLV-I pseudotype virions carrying a selektable marker gene. Virology, 180: 420-424,
25. Wilk, T., Pfeifer, T. and Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology, 189: 167-177.
26. Wong-Staal, F., Gallo, R.C., Chang, N.T., Ghrayeb, J., Papas, T.S., Lautenberger, J.A., Pearson, M.L., Petteway, S.R.Jr., Ivanoff, L., Baumeister, K., Whitehorn, E.A., Rafalski, J.A., Doran, E.R., Josephs, S.J., Starcich, B., Livak, K.J., Patarca, R., Haseltine, W.A. and Ratner, L. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, 313: 277-284.
27. Yu, M., Poeschla, E. and Wong-Stall, F. (1994). Progress towards gene therapy for HIV infection. Gene Ther., 1: 13-26.
28. Zhang, Z.-Q., Notermans, D.W., Sedgewick, G., Cavert, W., Wietgreffe, S., Zupancic, M., Gebhard, K., Henry, K., Boies, L., Chen, Z., Jenkins, M., Mills, R., McDade, H., Goodwin, C., Schuwirth C.M., Danner, S.A. and Haase, A.T. (1998). Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA, 95: 1154-1159.